Article

Wavefront measurement methods discussed

The only constant in the relatively young life of refractive surgery has been change. Even now as our patients reap the rewards of decades of research in the form of customized wavefront ablation, currently unforeseen improvements are inevitable.

Editor’s Note: In the following article, Barrie Soloway, MD, describes why he believes the Zernike polynomial is the optimal methodology for describing wavefront error. In another report , the role of the Fou- rier-based fitting method as an alternative to Zernike polynomials is covered.

For instance, the Zernike polynomial's role as the optimal methodology for describing wavefront error has recently been challenged.

As this alternative makes inroads into the Zeitgeist of refractive surgery, a pair of questions must be answered. Why has Zernike reigned as the optimal choice for wavefront error measurement, and is the proposed use of Fourier an example of implementing change simply for the sake of change?

To illustrate this, the effects of higher-order aberrations on two sets of eyes were compared (Figure 1). The data in blue represent 100 normal eyes prior to any refractive treatment, and show that beyond the sixth order there is essentially no impact. The data in red represent 20 eyes with high levels of higher-order wavefront error.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
© 2025 MJH Life Sciences

All rights reserved.